Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Sprecher

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Archives of Pediatrics & Adolescent Medicine|January 1, 1997
Lipoprotein and apolipoprotein differences in black and white girls. The National Heart, Lung, and Blood Institute Growth and Health StudyD L Sprecher, J A Morrison, L A Simbartl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1985
Estimation of VLDL cholesterol in hyperlipidemiaP W Wilson, L A Zech, R E Gregg, et al.
Biochemical and Biophysical Research Communications|August 16, 1990
Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defectS Yamashita, D Y Hui, D L Sprecher, et al.
The Journal of Biological Chemistry|July 25, 1986
Human preproapolipoprotein C-II. Analysis of major plasma isoformsS S Fojo, L Taam, T Fairwell, et al.
Atherosclerosis|November 15, 1996
Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levelsE J Schaefer, S Lamon-Fava, T Cole, et al.
The Journal of Clinical Investigation|February 1, 1986
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patientsG Baggio, E Manzato, C Gabelli, et al.
JAMA|November 22, 2001
Association between myeloperoxidase levels and risk of coronary artery diseaseR Zhang, M L Brennan, X Fu, et al.
The American Journal of Cardiology|July 1, 1984
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patientsD L Sprecher, E J Schaefer, K M Kent, et al.
Annals of Internal Medicine|April 1, 1994
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patientsD L Sprecher, J Abrams, J W Allen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1995
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitorJ W Nawrocki, S R Weiss, M H Davidson, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Archives of Pediatrics & Adolescent Medicine|January 1, 1997
Lipoprotein and apolipoprotein differences in black and white girls. The National Heart, Lung, and Blood Institute Growth and Health StudyD L Sprecher, J A Morrison, L A Simbartl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1985
Estimation of VLDL cholesterol in hyperlipidemiaP W Wilson, L A Zech, R E Gregg, et al.
Biochemical and Biophysical Research Communications|August 16, 1990
Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defectS Yamashita, D Y Hui, D L Sprecher, et al.
The Journal of Biological Chemistry|July 25, 1986
Human preproapolipoprotein C-II. Analysis of major plasma isoformsS S Fojo, L Taam, T Fairwell, et al.
Atherosclerosis|November 15, 1996
Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levelsE J Schaefer, S Lamon-Fava, T Cole, et al.
The Journal of Clinical Investigation|February 1, 1986
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patientsG Baggio, E Manzato, C Gabelli, et al.
JAMA|November 22, 2001
Association between myeloperoxidase levels and risk of coronary artery diseaseR Zhang, M L Brennan, X Fu, et al.
The American Journal of Cardiology|July 1, 1984
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patientsD L Sprecher, E J Schaefer, K M Kent, et al.
Annals of Internal Medicine|April 1, 1994
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patientsD L Sprecher, J Abrams, J W Allen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1995
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitorJ W Nawrocki, S R Weiss, M H Davidson, et al.
Pageof 8